Skip to content

holidravel.com

Subscribe To Our Newsletter

16-month-old baby denied life-saving drug by Louisiana Medicaid as it’s too expensive

Posted on December 6, 2019 By admin No Comments on 16-month-old baby denied life-saving drug by Louisiana Medicaid as it’s too expensive
  • Facebook
  • Twitter
  • Pinterest
  • LinkedIn

[ad_1]

A 16-month-old boy has been denied a potential cure to a life-threatening condition, as the drug is too expensive.

According to reports, Louisiana Medicaid has refused to cover the cost of the drug that could save little Axel Dennis’ life.

The boy was diagnosed with Spinal Muscular Atrophy Type 1 at just five weeks old. SMA is a genetic disease that affects muscle growth and movement in its victims.

This baby was denied services by the… https://t.co/MSgcoeIVmU

— Melissa (@RevolutionBaby9) December 5, 2019

As per WBRZ, Axel’s mother says her son’s muscles simply aren’t receiving messages from his brain.

“We were told one to two years and bring him home and enjoy him the best we could, but there were no guarantees of his life span,” mom Andrea James said.

Back in January, Axel lost the ability to smile. The FDA approved the drug Zolgensma for children – known to have a marked effect on the condition – below the age of two suffering from SMA earlier this year.

The issue lies in the exorbitant cost of the medicine, which stands at more than $2 million for a single dose.

Thus far, Axel’s Louisiana Medicaid have refused to foot the bill.

James explained: “We’ve been denied twice and now we’re applying for the State Fair Hearing. I think that they just don’t want to pay the price.”

Axel Dennis is a 16-month old baby, whose life since birth has been an uphill battle. https://t.co/Ko5hbWg2lM pic.twitter.com/uUjBkHXVda

— Activist Post (@ActivistPost) December 5, 2019

The denial letter claims Axel doesn’t meet certain criteria to receive the drug, placing this innocent little boy in a desperate race against time.

“The money’s been spent to prove that it’ll benefit these kids,” she said. “It will save their lives, as close to a cure as we’ve come and as what anything could be really. I say to the state, save his life, give him a chance to walk, give him a chance to earn his smile back.”

In eight months time, Axel turns two, after which the FDA will not approve the drug for him. He is currently administered a spinal injection of Spinraza every four months, though he is forced to undergo anaesthesia each time and it can often be traumatizing.

His family have set up a GoFundMe page and Facebook group to try and rally support for Axel, whose life could well be changed for the better if he is given Zolgensma.

It pains me to hear that a little boy might be missing out on a life-changing drug simply due to money.

Share this article far and wide and let’s help raise awareness of Axel’s plight and condition.

The post 16-month-old baby denied life-saving drug by Louisiana Medicaid as it’s too expensive appeared first on Newsner English.



[ad_2]

  • Facebook
  • Twitter
  • Pinterest
  • LinkedIn
Recommended

Post navigation

Previous Post: Teen siblings killed in murder-suicide after argument with mom’s boyfriend
Next Post: Couple buy baby gift only to discover semi-automatic rifle with live ammo inside

Related Posts

God’s love is enough Recommended
A Minister Decided To Do Something A Little Different. – Recommended
Lady Gaga’s wardrobe Recommended
When you finish talking bad about me Recommended
Can You Solve This Math Question That Left the Internet Divided? Recommended
6 Clear Signs That You Don’t Have Enough Oxygen In Your Blood Recommended

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Subscribe To Our Newsletter

Copyright © 2022 holidravel.com.

Powered by PressBook Grid Blogs theme